Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 USD | -4.60% | +8.36% | -3.26% |
May. 08 | BofA Securities Starts Sutro Biopharma With Buy Rating | MT |
Apr. 30 | Sutro Biopharma, Inc. Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial | CI |
Business Summary
Number of employees: 302
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 68 | 100.0 % | 154 | 100.0 % | +126.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 68 | 100.0 % | 154 | 100.0 % | +126.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 09-01-13 |
Jane Chung
PSD | President | 53 | 21-08-08 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 13-01-30 |
Steve Michel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 20-05-20 |
Chief Tech/Sci/R&D Officer | - | 23-09-17 | |
Henry Heinsohn
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Borgman
CTO | Chief Tech/Sci/R&D Officer | 56 | 23-02-27 |
Public Communications Contact | 67 | 07-12-31 | |
Werner Rubas
PRN | Corporate Officer/Principal | - | 21-09-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 19-06-23 |
James Panek
BRD | Director/Board Member | 71 | 20-01-06 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Joseph Lobacki
BRD | Director/Board Member | 65 | 17-01-31 |
William Newell
CEO | Chief Executive Officer | 66 | 09-01-13 |
Michael Dybbs
BRD | Director/Board Member | 49 | 18-07-24 |
Heidi Hunter
BRD | Director/Board Member | 66 | 21-11-18 |
Jon Wigginton
BRD | Director/Board Member | 62 | 20-11-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 81,764,683 | 81,012,202 ( 99.08 %) | 0 | 99.08 % |
Company contact information
Sutro Biopharma, Inc.
111 Oyster Point Boulevard
94080, South San Francisco
+650 881 6500
http://www.sutrobio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.26% | 339M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- STRO Stock
- Company Sutro Biopharma, Inc.